Macromoltek revolutionizes antibody design with its proprietary platform for rapid, accurate, and credible de novo drug design. We work with large biopharmas and smaller biotechs to tackle challenging targets.
Macromoltek is a computational drug discovery company dedicated to the advancement of antibody drug development through strategic partnerships. We design custom antibodies in one week using computational modeling.
Pharmaceutical companies, biotechnology companies, and research institutions.
